Top Markets
#1 QuantixAI QuantixAI +102.94%
#2 MetaDAO MetaDAO +28.44%
#3 龙虾 (Lobster) 龙虾 (Lobster) +27.94%
#4 Rain Rain +23.22%
#5 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +19.58%
#6 Bedrock Bedrock +18.45%
#7 Pons Pons +18.33%
#8 Prom Prom +15.79%
#9 Humanity Humanity +14.45%
#10 Stacks Stacks +11.76%
Coin of the day
QuantixAI QuantixAI
Settings
Language
ENGLISH
Currency
USD
Theme
Shanghai Allist Pharmaceuticals Co., Ltd. Shanghai Allist Pharmaceuticals Co., Ltd.

Shanghai Allist Pharmaceuticals Co., Ltd.

688578
Rank in Stocks #2712
Established in 2004, Shanghai Allist Pharmaceuticals Co., Ltd. is a Chinese... Established in 2004, Shanghai Allist Pharmaceuticals Co., Ltd. is a Chinese enterprise dedicated to the innovation and development of medicinal products. Headquartered in Shanghai, the company focuses its efforts on creating therapeutic agents specifically for the treatment of various tumor and cancer-related conditions.
Share Price
$16.52
Market Cap
$7.43B
Change (1 day)
1.61%
Change (1 year)
25.98%
Country
CN
Trade Shanghai Allist Pharmaceuticals Co., Ltd. (688578)

Category

Healthcare
Revenue for Shanghai Allist Pharmaceuticals Co., Ltd. (688578)
Revenue in Aug 2026 TTM: 0
According to Shanghai Allist Pharmaceuticals Co., Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Shanghai Allist Pharmaceuticals Co., Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH